Affiliation:
1. JMI Laboratories, North Liberty, Iowa, USA
2. University of Iowa, Iowa City, Iowa, USA
Abstract
We evaluated the activity of rezafungin and comparators, using Clinical and Laboratory Standards Institute (CLSI) broth microdilution methods, against a worldwide collection of 2,205 invasive fungal isolates recovered from 2016 to 2018.
Candida
(
n
= 1,904 isolates; 6 species),
Cryptococcus neoformans
(
n
= 73),
Aspergillus fumigatus
(
n
= 183), and
Aspergillus flavus
(
n
= 45) isolates were tested for their susceptibility (S) to rezafungin as well as the comparators caspofungin, anidulafungin, micafungin, and azoles.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference50 articles.
1. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
2. Fluconazole resistance in Candida species: a current perspective
3. Lockhart SR, Berkow EL, 2019. Antifungal agents, p 2319–2333. In Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Patel R, Richter SS, Warnock DW (ed), Manual of clinical microbiology, 12th ed, vol 2. ASM Press, Washington, DC.
4. Antifungal use in hospitalized adults in U.S. academic health centers
5. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献